James Hardie Industries plc

Listed Company

JHIUFCIK 0001159152OTCLarge AcceleratedConcrete Products, Except Block & BrickIEFY ends Mar 31

Period

FY 2026

Revenue

$4.84B

Net Income

$104.00M

Total Assets

$13.69B

Equity

$6.43B

Shares Out

580.31M

Op. Cash Flow

$589.80M

Business

James Hardie Industries plc is a foreign private issuer in Concrete Products, Except Block & Brick, headquartered in Ireland. Shares trade on NYSE under the ticker JHX.

Auto-generated from company profile

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	Mar 31, 2026 2026-03-31	Mar 31, 2025 2025-03-31	Mar 31, 2024 2024-03-31
Net sales	4,836	3,878	3,936
Cost of goods sold	3,106	2,373	2,348
Gross profit	1,730	1,505	1,588
Selling, general and administrative expenses	946	596	602
Research and development expenses	61	49	47
Restructuring, net	16	50	20
Acquisition related expenses	207	17	0
Asbestos adjustments	52	138	152
Operating income	448	656	767
Interest, net	231	10	15
Other expense (income), net	−10	−200,000	3
Income before income taxes	207	645	755
Income tax expense	103	221	245
Net income	104	424	510
Income per share:	—	—	—
Basic (in dollars per share)	0.19	0.98	1.16
Diluted (in dollars per share)	0.19	0.98	1.16
Weighted average common shares outstanding (Millions):	—	—	—
Basic (in shares)	542	431	438
Diluted (in shares)	546	432	440
Comprehensive income, net of tax:	—	—	—
Net income	104	424	510
Cash flow hedges	3	−100,000	0
Pension adjustments	−1	−100,000	500,000
Currency translation adjustments	8	2	−15
Reclassification of other comprehensive income	0	−9	0
Comprehensive income	116	434	495

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	Mar 31, 2026 2026-03-31	Mar 31, 2025 2025-03-31
Assets	—	—
Current assets:	—	—
Cash and cash equivalents	269	563
Restricted cash and cash equivalents	5	5
Restricted cash and cash equivalents - Asbestos	70	38
Restricted short-term investments - Asbestos	199	176
Accounts and other receivables, net	517	392
Inventories	636	347
Prepaid expenses and other current assets	114	101
Assets held for sale	11	73
Insurance receivable - Asbestos	4	6
Workers’ compensation - Asbestos	3	2
Total current assets	1,827	1,702
Property, plant and equipment, net	3,085	2,169
Operating lease right-of-use-assets	133	70
Finance lease right-of-use-assets	101	3
Goodwill	4,780	194
Intangible assets, net	3,340	146
Insurance receivable - Asbestos	21	23
Workers’ compensation - Asbestos	19	17
Deferred income taxes	73	600
Deferred income taxes - Asbestos	283	285
Other assets	27	22
Total assets	13,689	5,230
Liabilities and Shareholders’ Equity	—	—
Current liabilities:	—	—
Accounts payable and accrued liabilities	713	446
Accrued payroll and employee benefits	168	133
Operating lease liabilities	33	22
Finance lease liabilities	6	1
Long-term debt, current portion	44	9
Accrued product warranties	11	7
Income taxes payable	13	10
Asbestos liability	128	119
Workers’ compensation - Asbestos	3	2
Other liabilities	40	59
Total current liabilities	1,157	810
Long-term debt	4,491	1,110
Deferred income taxes	400	121
Operating lease liabilities	114	64
Finance lease liabilities	98	2
Accrued product warranties	53	27
Asbestos liability	880	864
Workers’ compensation - Asbestos	19	17
Other liabilities	50	54
Total liabilities	7,263	3,068
Commitments and contingencies (Note 15)	—	—
Shareholders’ equity:	—	—
Common stock, Euro 0.59 par value, 2.0 billion shares authorized; 580,174,308 shares issued and outstanding at March 31, 2026 and 429,818,781 shares issued and outstanding at March 31, 2025	327	222
Additional paid-in capital	4,315	272
Retained earnings	1,830	1,726
Accumulated other comprehensive loss	−46	−58
Total shareholders’ equity	6,426	2,162
Total liabilities and shareholders’ equity	13,689	5,230

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	Mar 31, 2026 2026-03-31	Mar 31, 2025 2025-03-31	Mar 31, 2024 2024-03-31
Cash Flows From Operating Activities	—	—	—
Net income	104	424	510
Adjustments to reconcile net income to net cash provided by operating activities:	—	—	—
Depreciation and amortization	494	216	185
Lease expense	42	33	27
Deferred income taxes	−18	62	35
Share-based compensation	38	23	28
Asbestos adjustments	52	138	152
Gain on sale of land	26	0	2
Non-cash restructuring expenses	24	38	20
Non-cash interest expense	9	2	2
Non-cash charge related to step up of inventory	48	0	0
Other, net	−42	−19	−30
Changes in operating assets and liabilities:	—	—	—
Accounts and other receivables	16	29	20
Inventories	49	16	−3
Operating lease assets and liabilities, net	−47	−34	−28
Prepaid expenses and other assets	1	41	22
Insurance receivable - Asbestos	−4	−4	−6
Accounts payable and accrued liabilities	30	18	47
Claims and handling costs paid - Asbestos	−107	−114	−116
Income taxes payable	2	−3	−5
Other accrued liabilities and interest	−34	62	62
Net cash provided by operating activities	590	803	914
Cash Flows From Investing Activities	—	—	—
Purchases of property, plant and equipment	384	422	449
Proceeds from sale of property, plant and equipment	108	400,000	4
Capitalized interest	6	21	20
Cash consideration for The AZEK Company acquisition, net of cash acquired	3,920	0	0
Purchase of restricted investments - Asbestos	190	183	144
Proceeds from restricted investments - Asbestos	183	179	138
Net cash used in investing activities	−4,209	−447	−471
Cash Flows From Financing Activities	—	—	—
Proceeds from term loans	2,500	0	300
Proceeds from senior secured notes	1,700	0	0
Proceeds from revolving credit facilities	130	0	95
Repayments of term loans	323	8	2
Repayments of revolving credit facilities	130	0	325
Repayment of senior unsecured notes	465	0	0
Debt issuance costs paid	42	0	1
Proceeds from issuance of shares	0	0	400,000
Proceeds from exercise of vested stock options	2	0	0
Share issuance costs due to AZEK acquisition	2	0	0
Repayment of finance lease obligations	5	1	1
Shares repurchased	0	150	271
Shares issued, net of cash paid for shares withheld for taxes	14	7	5
Net cash provided by (used in) financing activities	3,351	−166	−210
Effects of exchange rate changes on cash and cash equivalents, restricted cash and restricted cash - Asbestos	7	−400,000	−3
Net (decrease) increase in cash and cash equivalents, restricted cash and restricted cash - Asbestos	−261	190	230
Cash and cash equivalents, restricted cash and restricted cash - Asbestos at end of period	—	—	—
Cash and cash equivalents, restricted cash and restricted cash - Asbestos at end of period	—	—	—
Non-Cash Investing and Financing Activities	—	—	—
Capital expenditures incurred but not yet paid	50	41	75
Non-cash ROU assets obtained in exchange for new lease liabilities	59	34	22
Non-cash consideration for AZEK acquisition	4,144	0	0
Supplemental Disclosure of Cash Flow Activities	—	—	—
Cash paid for interest	208	64	42
Cash payment for income taxes, net	85	128	183
Cash paid to AICF	125	99	92

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro